This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $249,108 to Brown University to conduct a multimodal study integrating biobehavioral markers and ecological assessment to examine how cognitive processes related to decision-making, such as reward motivation and inhibitory control, relate to cannabis use among young adults following a potentially traumatic event. The study will leverage the...
The National Institute on Drug Abuse (NIDA) awarded Duke University a Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate digital envirotyping methods for characterizing the everyday environments of people who smoke. The $763,766 award, which runs from July 2025 to March 2030, aims to (1) advance digital envirotyping and enviromarker development to identify environmental triggers of smoking relapse, and (2) increase understanding of...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method study on momentary distress intolerance and its relationship to cigarette smoking among adults with emotional distress. The $233,913 award to Rutgers, The State University will fund a 5-year research plan involving qualitative investigation, ecological momentary assessment, and longitudinal modeling to better understand...
This Project Grant award of $1,838,237, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the neuronal circuits through which chronic stress promotes habit formation. The award, effective September 15, 2024 and ending May 31, 2029, will be executed by the University of California, Los Angeles (UCLA). The research aims to expose how opposing amygdala-striatal pathways in the brain enable...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $3,580,802 to Yale University to conduct research on stress-immune mechanisms in people living with HIV, cannabis use disorder, and depression. The key goals are to: Determine the hypothalamic-pituitary-adrenal (HPA) and immune response to acute stress among healthy controls, people living with HIV, and those with complex morbidity (HIV,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $425,636 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct patient-oriented substance use and smoking cessation research in the context of HIV treatment and prevention. The key activities funded under this 5-year award include: 1) Mentoring junior researchers (pre- and post-doctoral fellows,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a study to identify modifiable momentary predictors of substance use in high-risk emergency medical services (EMS) clinicians. The $147,486 award to Trustees of Dartmouth College will support a 28-day intensive longitudinal study using ecological momentary assessments to examine the temporal relationships between stress, self-regulation, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $107,002 to The New School to conduct a cross-sectional, quantitative study exploring the impact of racism-related experiences, including historical trauma, on post-traumatic stress disorder (PTSD) symptoms and polysubstance use among Black young adults. The study aims to measure the comprehensive effects of present-day racism (major discriminatory...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This Project Grant award, with a total funding amount of $957,600.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will be used by Drexel University to develop a novel framework for community-directed research approaches that seek to reduce intersectional and intergenerational inequities in commercial tobacco use among Black and Latinx adult sexual and gender minorities in Philadelphia. Key activities...